'Breakthrough' dementia drug looks to stop disease in its tracks
'Breakthrough' dementia drug looks to stop disease in its tracks
Filamon Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its breakthrough dementia treatment. ALPHA-003 is designed to preserve the integrity of vital brain cell structures and protect them against destruction caused by brain inflammation.
Yeah we'll see when the big studies come in with data.
Big if true
Tau seems like the only remaining target for treating alzheimers so it good to see a new drug thats active in that space. Antiamyloid treatments have been ineffective. Interesting that it strenthens healthy tau structures rather than reducing overall levels of this useful/vital molecule Compared to this drug https://www.ucl.ac.uk/news/2023/apr/first-gene-silencing-drug-alzheimers-disease-shows-promise for example